Birdwatch Note
2024-10-17 12:54:21 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
ブログには、スパイク蛋白が血栓を形成して、心筋梗塞になる、というような噂が記載されていますが、医療記録のデータベースを使ったこうした研究は世界で無数に行われており、そのメタアナリシスによると、mRNAワクチン接種者はメタ解析によると主たる血栓症のリスクが未接種者より低く 下記3.4.2 https://www.mdpi.com/2076-393X/10/4/596 心筋梗塞リスクの上昇も検出できていません。 https://www.tandfonline.com/doi/full/10.1080/14760584.2023.2150169 また、厚労省の副反応検討部会でも肺塞栓症の客観的医療記録とmRNAワクチン接種の間の関連を調べた研究をまとめ基本的に肺塞栓の接種後の客観的医療記録のリスク上昇がほぼすべての条件で検出できない事をまとめています。 https://www.mhlw.go.jp/content/10900000/89_risk.pdf
Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1846884245098422323
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1846897538152190102
- noteId - 1846897538152190102
- participantId -
- noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
- createdAtMillis - 1729169661449
- tweetId - 1846884245098422323
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- ブログには、スパイク蛋白が血栓を形成して、心筋梗塞になる、というような噂が記載されていますが、医療記録のデータベースを使ったこうした研究は世界で無数に行われており、そのメタアナリシスによると、mRNAワクチン接種者はメタ解析によると主たる血栓症のリスクが未接種者より低く 下記3.4.2 https://www.mdpi.com/2076-393X/10/4/596 心筋梗塞リスクの上昇も検出できていません。 https://www.tandfonline.com/doi/full/10.1080/14760584.2023.2150169 また、厚労省の副反応検討部会でも肺塞栓症の客観的医療記録とmRNAワクチン接種の間の関連を調べた研究をまとめ基本的に肺塞栓の接種後の客観的医療記録のリスク上昇がほぼすべての条件で検出できない事をまとめています。 https://www.mhlw.go.jp/content/10900000/89_risk.pdf
Note Ratings
| rated at | rated by | |
| 2024-10-18 06:12:47 -0500 | Rating Details | |
| 2024-10-17 22:50:55 -0500 | Rating Details | |
| 2024-10-17 22:10:58 -0500 | Rating Details | |
| 2024-10-17 21:36:31 -0500 | Rating Details | |
| 2024-10-17 21:00:42 -0500 | Rating Details | |
| 2024-10-17 19:37:40 -0500 | Rating Details | |
| 2024-10-17 19:02:31 -0500 | Rating Details | |
| 2024-10-17 18:12:36 -0500 | Rating Details | |
| 2024-10-17 16:12:12 -0500 | Rating Details | |
| 2024-10-17 13:27:51 -0500 | Rating Details | |
| 2024-10-17 10:42:58 -0500 | Rating Details | |
| 2024-10-17 10:37:10 -0500 | Rating Details | |
| 2024-10-17 09:27:38 -0500 | Rating Details | |
| 2024-10-17 09:27:07 -0500 | Rating Details | |
| 2024-10-17 09:06:30 -0500 | Rating Details | |
| 2024-10-17 08:37:46 -0500 | Rating Details | |
| 2024-10-17 08:22:42 -0500 | Rating Details | |
| 2024-10-17 08:00:09 -0500 | Rating Details | |
| 2024-10-18 05:22:39 -0500 | Rating Details | |
| 2024-10-18 03:25:06 -0500 | Rating Details | |
| 2024-10-17 22:18:41 -0500 | Rating Details | |
| 2024-10-17 21:59:22 -0500 | Rating Details | |
| 2024-10-17 21:37:58 -0500 | Rating Details | |
| 2024-10-17 21:01:09 -0500 | Rating Details | |
| 2024-10-17 18:40:49 -0500 | Rating Details | |
| 2024-10-17 18:07:05 -0500 | Rating Details | |
| 2024-10-17 18:01:45 -0500 | Rating Details | |
| 2024-10-17 17:30:42 -0500 | Rating Details | |
| 2024-10-17 17:06:03 -0500 | Rating Details | |
| 2024-10-17 16:05:04 -0500 | Rating Details | |
| 2024-10-17 12:42:49 -0500 | Rating Details | |
| 2024-10-17 11:15:37 -0500 | Rating Details | |
| 2024-10-17 10:20:06 -0500 | Rating Details | |
| 2024-10-17 10:13:35 -0500 | Rating Details | |
| 2024-10-17 10:05:49 -0500 | Rating Details | |
| 2024-10-17 09:24:03 -0500 | Rating Details | |
| 2024-10-17 08:34:49 -0500 | Rating Details | |
| 2024-10-17 08:33:53 -0500 | Rating Details | |
| 2024-10-17 08:15:18 -0500 | Rating Details | |
| 2024-10-17 08:14:59 -0500 | Rating Details | |
| 2024-10-17 08:14:27 -0500 | Rating Details | |
| 2024-10-17 08:01:28 -0500 | Rating Details | |
| 2024-10-17 20:16:25 -0500 | Rating Details | |
| 2024-10-17 17:51:41 -0500 | Rating Details | |
| 2024-10-17 13:11:18 -0500 | Rating Details | |
| 2024-10-17 12:18:49 -0500 | Rating Details | |
| 2024-10-17 09:06:59 -0500 | Rating Details | |
| 2024-10-17 09:00:55 -0500 | Rating Details | |
| 2024-10-17 08:55:48 -0500 | Rating Details | |
| 2024-10-17 08:35:55 -0500 | Rating Details | |
| 2024-10-17 08:29:47 -0500 | Rating Details | |
| 2024-10-17 08:21:40 -0500 | Rating Details | |
| 2024-10-17 08:12:49 -0500 | Rating Details | |
| 2024-10-17 08:10:48 -0500 | Rating Details | |
| 2024-10-17 08:09:33 -0500 | Rating Details | |
| 2024-10-17 08:05:06 -0500 | Rating Details | |
| 2024-10-18 10:48:31 -0500 | Rating Details | |
| 2024-10-18 01:05:14 -0500 | Rating Details | |
| 2024-10-17 20:14:58 -0500 | Rating Details | |
| 2024-10-17 18:40:17 -0500 | Rating Details | |
| 2024-10-17 17:25:34 -0500 | Rating Details | |
| 2024-10-17 16:55:19 -0500 | Rating Details | |
| 2024-10-17 16:49:20 -0500 | Rating Details | |
| 2024-10-17 16:28:06 -0500 | Rating Details | |
| 2024-10-17 10:13:55 -0500 | Rating Details | |
| 2024-10-17 09:44:15 -0500 | Rating Details | |
| 2024-10-17 08:57:08 -0500 | Rating Details | |
| 2024-10-17 08:52:55 -0500 | Rating Details | |
| 2024-10-17 08:49:21 -0500 | Rating Details | |
| 2024-10-17 08:48:34 -0500 | Rating Details | |
| 2024-10-17 08:28:00 -0500 | Rating Details | |
| 2024-10-17 08:23:47 -0500 | Rating Details | |
| 2024-10-17 08:20:28 -0500 | Rating Details | |
| 2024-10-17 08:11:13 -0500 | Rating Details | |
| 2024-10-17 08:03:19 -0500 | Rating Details |